EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Michele Fusaroli, Francesco Salvo, Bernard Begaud, Thamir M AlShammari, Andrew Bate, Vera Battini, Andreas Brueckner, Gianmario Candore, Carla Carnovale, Salvatore Crisafulli, Paola Maria Cutroneo, Charles Dolladille und 22 weitere

Drug Safety · 2024-06 · 47 (6) · 585-599

DOI: 10.1007/s40264-024-01423-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 07.05.2024. Verfasst von Michele Fusaroli und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. michele.fusaroli2@unibo.it. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 382-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alma Mater Studiorum - Università di Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In pharmacovigilance, disproportionality analyses based on individual case safety reports are widely used to detect safety signals. Unfortunately, publishing disproportionality analyses lacks specific guidelines, often leading to incomplete and ambiguous reporting, and carries the risk of incorrect conclusions when data are not placed in the correct context. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV) statement was developed to address this issue by promoting transparent and comprehensive reporting of disproportionality studies. While the statement paper explains in greater detail the procedure followed to develop these guidelines, with this explanation paper we present the 14 items retained for READUS-PV guidelines, together with an in-depth explanation of their rationale and bullet points to illustrate their practical implementation. Our primary objective is to foster the adoption of the READUS-PV guidelines among authors, editors, peer reviewers, and readers of disproportionality analyses. Enhancing transparency, completeness, and accuracy of reporting, as well as proper interpretation of their results, READUS-PV guidelines will ultimately facilitate evidence-based decision making in pharmacovigilance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansGuidelines as Topic

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. michele.fusaroli2@unibo.it.
  • Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.
  • Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.
  • Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.
  • College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.
  • Global Safety, GSK, Brentford, UK.

Förderung

  • Alma Mater Studiorum - Università di Bologna

Zitieren

APA

Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M. D., Faillie, J. L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., …, & Khouri, C. (2024). The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. Drug Safety, 47(6), 585-599. https://doi.org/10.1007/s40264-024-01423-7

Vancouver

Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, et al. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. Drug Safety. 2024;47(6):585-599. doi:10.1007/s40264-024-01423-7

BibTeX
@article{Fusaroli2024,
  author = {Fusaroli, Michele and Salvo, Francesco and Begaud, Bernard and AlShammari, Thamir M and Bate, Andrew and Battini, Vera and Brueckner, Andreas and Candore, Gianmario and Carnovale, Carla and Crisafulli, Salvatore and Cutroneo, Paola Maria and Dolladille, Charles and Drici, Milou-Daniel and Faillie, Jean-Luc and Goldman, Adam and Hauben, Manfred and Herdeiro, Maria Teresa and Mahaux, Olivia and Manlik, Katrin and Montastruc, François and Noguchi, Yoshihiro and Norén, G Niklas and Noseda, Roberta and Onakpoya, Igho J and Pariente, Antoine and Poluzzi, Elisabetta and Salem, Myriam and Sartori, Daniele and Trinh, Nhung T H and Tuccori, Marco and van Hunsel, Florence and van Puijenbroek, Eugène and Raschi, Emanuel and Khouri, Charles},
  title = {The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration},
  journal = {Drug Safety},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {585--599},
  doi = {10.1007/s40264-024-01423-7}
}
Kostenlos starten →